Expression of VEGF, EGF, and Their Receptors in Squamous Esophageal Mucosa, with Correlations to Histological Findings and Endoscopic Minimal Changes, in Patients with Different GERD Phenotypes.
EGF
GERD
VEGF
growth factors
minimal change esophagitis
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
27 04 2022
27 04 2022
Historique:
received:
07
03
2022
revised:
15
04
2022
accepted:
21
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
Gastroesophageal reflux disease (GERD) may present as nonerosive reflux disease (NERD), erosive esophagitis (EE), or be complicated by Barrett's esophagus (BE). The explanation as to what determines the phenotype of GERD is awaited. Therefore, we assessed the correlation between the growth factors expression and endoscopic as histologic findings in GERD patients. The squamous esophageal epithelium of 50 patients (20-NERD, 7-EE, 15-BE, 8 controls) was examined by: (1) magnification endoscopy with evaluation of minimal GERD changes such as: microerosions, white spots, palisade blood vessels visibility, and intrapapillary capillary loops (IPCLs) appearance, (2) histology, (3) immunohistochemistry with evaluation of the expression of vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and their receptors (VEGFR and EGFR). The expression of VEGF, but not VEGFR, EGF, and EGFR, was significantly increased in EE patients compared to NERD patients and controls. VEGF levels correlated significantly with the presence of white spots, but not with other minimal endoscopic and histologic features. The EGFR expression correlated positively with basal cell hyperplasia and enlarged IPCLs. Our findings suggest a correlation between growth factors expression and findings in conventional endoscopy, formation of endoscopic minimal changes, and histologic lesions.
Sections du résumé
BACKGROUND
Gastroesophageal reflux disease (GERD) may present as nonerosive reflux disease (NERD), erosive esophagitis (EE), or be complicated by Barrett's esophagus (BE). The explanation as to what determines the phenotype of GERD is awaited. Therefore, we assessed the correlation between the growth factors expression and endoscopic as histologic findings in GERD patients.
METHODS
The squamous esophageal epithelium of 50 patients (20-NERD, 7-EE, 15-BE, 8 controls) was examined by: (1) magnification endoscopy with evaluation of minimal GERD changes such as: microerosions, white spots, palisade blood vessels visibility, and intrapapillary capillary loops (IPCLs) appearance, (2) histology, (3) immunohistochemistry with evaluation of the expression of vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and their receptors (VEGFR and EGFR).
RESULTS
The expression of VEGF, but not VEGFR, EGF, and EGFR, was significantly increased in EE patients compared to NERD patients and controls. VEGF levels correlated significantly with the presence of white spots, but not with other minimal endoscopic and histologic features. The EGFR expression correlated positively with basal cell hyperplasia and enlarged IPCLs.
CONCLUSIONS
Our findings suggest a correlation between growth factors expression and findings in conventional endoscopy, formation of endoscopic minimal changes, and histologic lesions.
Identifiants
pubmed: 35564692
pii: ijerph19095298
doi: 10.3390/ijerph19095298
pmc: PMC9102479
pii:
doi:
Substances chimiques
Vascular Endothelial Growth Factor A
0
Epidermal Growth Factor
62229-50-9
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943
pubmed: 16928254
J Clin Gastroenterol. 2017 Jul;51(6):467-478
pubmed: 28591069
Dig Dis Sci. 2013 Jan;58(1):115-22
pubmed: 22875307
Dig Dis. 2004;22(2):221-7
pubmed: 15383765
Am J Gastroenterol. 2022 Jan 1;117(1):27-56
pubmed: 34807007
Aliment Pharmacol Ther. 2010 Sep;32(6):720-37
pubmed: 20662774
Hepatogastroenterology. 2006 May-Jun;53(69):361-5
pubmed: 16795973
Clin Gastroenterol Hepatol. 2012 Aug;10(8):863-873.e3
pubmed: 22401904
Am J Med Sci. 2015 May;349(5):385-91
pubmed: 25789686
Adv Wound Care (New Rochelle). 2014 Oct 1;3(10):647-661
pubmed: 25302139
Gastroenterology. 2009 Nov;137(5):1776-84
pubmed: 19660463
Dig Dis Sci. 2014 May;59(5):949-57
pubmed: 24357184
Am J Gastroenterol. 2004 Jan;99(1):13-22
pubmed: 14687135
Adv Wound Care (New Rochelle). 2013 Feb;2(1):24-29
pubmed: 24527320
J Gastroenterol. 2013 Apr;48(4):473-82
pubmed: 23001252
BMC Gastroenterol. 2016 Jan 14;16:4
pubmed: 26762316
Gut. 1992 Nov;33(11):1448-53
pubmed: 1452065
Pathologica. 2020 Sep;112(3):117-127
pubmed: 33179616
World J Surg Oncol. 2012 May 16;10:84
pubmed: 22591510
Gastrointest Endosc Clin N Am. 2017 Jul;27(3):353-364
pubmed: 28577761
Scand J Gastroenterol. 2005 Mar;40(3):275-85
pubmed: 15932168
Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G665-73
pubmed: 16306134
Am J Gastroenterol. 1994 Aug;89(8):1177-84
pubmed: 8053431
JAMA. 2016 May 17;315(19):2104-12
pubmed: 27187303
J Neurogastroenterol Motil. 2021 Oct 30;27(4):453-481
pubmed: 34642267
Dig Dis. 2004;22(2):196-201
pubmed: 15383761
Adv Med Sci. 2018 Sep;63(2):359-366
pubmed: 30114679
Gut. 2005 May;54(5):710-7
pubmed: 15831922
Wound Repair Regen. 2002 Jul-Aug;10(4):245-51
pubmed: 12191007
Gastroenterology. 2015 Dec;149(7):1731-1741.e3
pubmed: 26327134
Pathologica. 2020 Sep;112(3):128-137
pubmed: 33179617
Pathologica. 2020 Sep;112(3):138-152
pubmed: 33179618
Curr Opin Pharmacol. 2017 Dec;37:93-99
pubmed: 29112883
Transl Res. 2008 Aug;152(2):81-7
pubmed: 18674742
Endoscopy. 2007 Mar;39(3):195-201
pubmed: 17236126